Michelle LaSpaluto - 07 Jan 2025 Form 4 Insider Report for CHIMERIX INC

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Michael Alrutz, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
07 Jan 2025
Net transactions value
$0
Form type
4
Filing time
10 Jan 2025, 15:01:12 UTC
Previous filing
16 Feb 2024
Next filing
31 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMRX Common Stock Award $0 +41,667 +31% $0.000000 176,252 07 Jan 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMRX Stock Option (Right to Buy) Award $0 +250,000 $0.000000 250,000 07 Jan 2025 Common Stock 250,000 $3.66 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares being reported are being issued pursuant to restricted unit awards ("RSUs"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 10,416 shares subject to the RSUs will vest on the one-year anniversary of the date of grant, 10,417 shares subject to the RSUs will vest on the second-year anniversary of the date of grant, 10,417 shares subject to the RSUs will vest on the third-year anniversary of the date of grant, and 10,417 shares subject to the RSUs will vest on the fourth-year anniversary of the date of grant.
F2 Includes: i) 15,560 shares acquired under the Issuer's Employee Stock Purchase Plan ("ESPP") on March 8, 2024; and ii) 8,026 shares acquired under the Issuer's ESPP on September 10, 2024.
F3 One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 36 equal monthly installments thereafter.